Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
BPH Impact IndexBosniak ClassificationCAPRA ScoreD'Amico Risk ClassificationEAU NMIBC Risk Groups (2021)EORTC Risk Tables for NMIBCFournier's Gangrene Severity IndexGUPI (Genitourinary Pain Index)Guy's Stone ScoreICIQ-UI SFIGCCCG ClassificationIIEF-5 / SHIMIIQ-7IMDC (Heng) Risk CriteriaIPSS ScoreNIH-CPSIOAB-V8PADUA Prediction ScorePI-RADS v2.1PSA DensityR.E.N.A.L. Nephrometry ScoreResidual Volume (PVR)S.T.O.N.E. NephrolithometrySFU Hydronephrosis GradingUDI-6VUR Grading
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

FDA MedWatchJun 16, 2026
Early Alert: Convenience Kit Issue from Windstone Medical Packaging, Inc.

Clinical Context

We think this might be relevant to the clinical guidance for Guy's Stone Score (GSS).

WHO NewsJun 15, 2026
Open letter to leaders of G7, G20, BRICS and all nations on finalizing the WHO Pandemic Agreement’s Pathogen Access and Benefit Sharing annex

Clinical Context

We think this might be relevant to the clinical guidance for Guy's Stone Score (GSS).

FDA MedWatchJun 10, 2026
FDA Approves Labeling Changes for Over-the-Counter (OTC) Weight Loss Drug alli (Orlistat) to Warn of Risk of Kidney Stones and Kidney Injury

Clinical Context

We think this might be relevant to the clinical guidance for Guy's Stone Score (GSS).

Guy's Stone Score

PCNL Complexity Grading

Clinical Parameters

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use Guy's Stone Score

Preoperative risk stratification for patients undergoing percutaneous nephrolithotomy (PCNL)
Counseling patients regarding expected stone-free rates and risk of complications
Planning surgical approach, number of tracts, operative time, and need for staged procedures
Comparing outcomes across different centers and surgeons
Stratifying cases for research studies and audit of PCNL results
Decision-making between PCNL, retrograde intrarenal surgery (RIRS), or shockwave lithotripsy (SWL) in borderline cases
Helping select patients suitable for tubeless PCNL versus standard drainage

Clinical Context and Stone Burden Assessment

Percutaneous nephrolithotomy remains the gold-standard treatment for large renal stones (>2 cm), staghorn calculi, and stones resistant to less invasive modalities. Stone complexity directly impacts surgical difficulty, operative time, radiation exposure, blood loss, transfusion rate, and stone-free rate. Guy's Stone Score (GSS) was designed as a simple, reproducible grading system using preoperative non-contrast CT (NCCT) to predict outcomes. It is particularly useful in settings where more complex nomograms may be impractical.

Preoperative Imaging Requirements

Non-contrast CT KUB (NCCT) is mandatory — provides accurate stone size, location, number, and anatomical details
Assessment of renal anatomy: calyceal orientation, infundibular length/width, pelvicalyceal system dilatation
Evaluation for anatomical abnormalities: horseshoe kidney, crossed fused ectopia, malrotation, spinal deformity
Identification of staghorn morphology (partial vs complete)
Measurement of stone burden (cumulative stone diameter or stone volume when possible)

Last Comprehensive Review: 2026

Related Tools

AAST Bladder Injury Scale
Urology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.